EG22944A - Systemic formulations - Google Patents

Systemic formulations

Info

Publication number
EG22944A
EG22944A EG20010999A EG20010999A EG22944A EG 22944 A EG22944 A EG 22944A EG 20010999 A EG20010999 A EG 20010999A EG 20010999 A EG20010999 A EG 20010999A EG 22944 A EG22944 A EG 22944A
Authority
EG
Egypt
Prior art keywords
systemic formulations
systemic
formulations
Prior art date
Application number
EG20010999A
Inventor
Lionel B Lowe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to EG20010999A priority Critical patent/EG22944A/en
Application granted granted Critical
Publication of EG22944A publication Critical patent/EG22944A/en

Links

EG20010999A 2001-09-19 2001-09-19 Systemic formulations EG22944A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EG20010999A EG22944A (en) 2001-09-19 2001-09-19 Systemic formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EG20010999A EG22944A (en) 2001-09-19 2001-09-19 Systemic formulations

Publications (1)

Publication Number Publication Date
EG22944A true EG22944A (en) 2002-01-13

Family

ID=31197732

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20010999A EG22944A (en) 2001-09-19 2001-09-19 Systemic formulations

Country Status (1)

Country Link
EG (1) EG22944A (en)

Similar Documents

Publication Publication Date Title
GB2359254B (en) Formulation
GB0319041D0 (en) Pharmaceutical Formulations
EP1391209A4 (en) Protein formulations
GB0000891D0 (en) Formulation
EP1353546A4 (en) Specification
GB0106601D0 (en) Antiperspirant formulations
GB0015490D0 (en) Novel formulations
GB0103638D0 (en) Pharmaceutical formulations
GB0120701D0 (en) Pharmaceutical formulations
GB0121715D0 (en) Pharmaceutical formulations
EP1370240A4 (en) Neuroprotectants formulations and methods
PL367280A1 (en) Agrochemical formulations
GB2380129B (en) Pharmaceutical formulations
GB0105560D0 (en) Pharmaceutical formulations
GB0111314D0 (en) Dermatological formulations
GB0125492D0 (en) Formulation
EG22944A (en) Systemic formulations
GB0115893D0 (en) Formulations
GB0124455D0 (en) Pharmaceutical formulations
HK1054508A1 (en) New formulation
GB2396812B (en) Formulation
GB2375048B (en) Formulation
GB0116619D0 (en) Formulation
GB0112497D0 (en) Formulation
GB0107226D0 (en) Formulations